Equinor
EQNR
41.61
-1.40
-3.26%
Equinor
US · EQNR
#198 by market cap
Listed 1970
41.61
-1.40
-3.26%
Live - 5344 symbols - heartbeat 43s ago
· 2026-10-08 07:00
Pre-market
42.96
+3.24%
After-hours
41.63
+0.05%
Overnight
42.66
+2.52%
- Market cap
- 98.61B
- P/E (TTM)i
- 11.28
- P/Bi
- 2.29
- EPSi
- 1.94
- Div yieldi
- 3.60%
- 52W posi
- 83%
Reader sentiment
Are you bullish or bearish on EQNR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.66, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +3.24% YoY
Margins
- Gross margin
- 36.23%
- Operating margin
- 23.37%
- Net margin
- 4.77%
Key ratios & quality
- Enterprise valuei
- 108.28B
- Altman Z-Scorei
- 2.66
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 78.56B | 62.91B | 45.75B | 88.74B | 149.00B | 106.85B | 102.50B | 105.83B |
| Gross profit | 30.79B | 20.18B | 9.53B | 41.87B | 88.81B | 48.04B | 42.63B | 38.35B |
| Selling & admin expenses | 758.00M | 809.00M | 706.00M | 780.00M | 986.00M | 1.22B | 1.26B | 1.21B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 19.38B | 8.68B | -3.89B | 32.95B | 77.74B | 35.23B | 30.35B | 24.73B |
| Pretax profit | 18.87B | 9.29B | -4.26B | 31.58B | 78.60B | 37.88B | 30.99B | 25.09B |
| Tax | 11.34B | 7.44B | 1.24B | 23.01B | 49.86B | 25.98B | 22.16B | 20.03B |
| Net profit | 7.54B | 1.85B | -5.50B | 8.58B | 28.74B | 11.90B | 8.83B | 5.06B |
| Basic EPS | 2 | 1 | -2 | 3 | 9 | 4 | 3 | 2 |
| Diluted EPS | 2.27 | 0.55 | -1.69 | 2.63 | 9.03 | 3.93 | 3.11 | 1.94 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 29.38B | 25.13B | 26.02B | 25.30B | 27.82B | 34.52B |
| Gross profit | 11.63B | 8.97B | 8.80B | 8.94B | 12.33B | 15.87B |
| Selling & admin expenses | 323.00M | 329.00M | 258.00M | 297.00M | 309.00M | 273.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 8.86B | 5.71B | 5.29B | 4.87B | 8.80B | 12.86B |
| Pretax profit | 8.89B | 5.76B | 4.67B | 5.77B | 9.74B | 13.03B |
| Tax | 6.26B | 4.44B | 4.87B | 4.46B | 6.64B | 8.19B |
| Net profit | 2.63B | 1.32B | -204.00M | 1.31B | 3.11B | 4.84B |
| Basic EPS | 1 | 1 | 0 | 1 | 1 | 2 |
| Diluted EPS | 0.96 | 0.50 | -0.08 | 0.52 | 1.24 | 1.99 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 26.06B | 24.78B | 32.19B | 62.50B | 78.17B | 62.05B | 53.19B | 38.94B |
| Cash & ST investments | 14.09B | 12.60B | 17.62B | 33.28B | 39.31B | 37.29B | 21.24B | 19.33B |
| Inventory | 2.14B | 3.36B | 3.08B | 3.40B | 5.21B | 3.81B | 4.03B | 3.33B |
| Total assets | 112.51B | 119.86B | 124.81B | 147.12B | 158.02B | 143.58B | 131.14B | 131.73B |
| Total current liabilities | 16.61B | 19.56B | 19.82B | 39.14B | 43.81B | 36.19B | 36.05B | 30.78B |
| Short-term debt | 2.46B | 4.09B | 5.78B | 6.39B | 5.62B | 7.28B | 8.47B | 5.24B |
| Long-term debt | 22.83B | 21.75B | 29.12B | 27.40B | 24.14B | 22.23B | 19.36B | 23.76B |
| Total liabilities | 69,518,000,000.00 | 78,702,000,000.00 | 90,917,000,000.00 | 108,096,000,000.00 | 104,032,000,000.00 | 95,080,000,000.00 | 88,761,000,000.00 | 91,230,000,000.00 |
| Total equity | 42.99B | 41.16B | 33.89B | 39.02B | 53.99B | 48.50B | 42.38B | 40.50B |
| Retained earnings | 38.79B | -- | 30.05B | 36.68B | 58.24B | 56.52B | 52.41B | 48.03B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 54.57B | 56.10B | 52.15B | 38.94B | 45.91B | 45.43B |
| Cash & ST investments | 24.85B | 23.80B | 22.39B | 19.33B | 20.10B | 23.73B |
| Inventory | 3.21B | 3.83B | 3.74B | 3.33B | 4.24B | 2.92B |
| Total assets | 137.90B | 139.09B | 135.85B | 131.73B | 141.15B | 140.90B |
| Total current liabilities | 35.54B | 38.27B | 35.21B | 30.78B | 37.05B | 38.63B |
| Short-term debt | 7.03B | 9.84B | 5.88B | 5.24B | 6.92B | 8.18B |
| Long-term debt | 20.50B | 22.36B | 22.90B | 23.76B | 22.16B | 21.59B |
| Total liabilities | 92,032,000,000.00 | 97,119,000,000.00 | 95,254,000,000.00 | 91,230,000,000.00 | 97,512,000,000.00 | 97,767,000,000.00 |
| Total equity | 45.86B | 41.97B | 40.59B | 40.50B | 43.64B | 43.13B |
| Retained earnings | 54.55B | 49.22B | 47.95B | 48.03B | 50.99B | 50.78B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 19.69B | 13.75B | 10.39B | 28.82B | 35.14B | 29.26B | 19.47B | 19.97B |
| Depreciation & amortization | 9.25B | 13.20B | 15.24B | 11.72B | 6.73B | 10.58B | 9.91B | 12.47B |
| Free cash flow | 8.33B | 3.55B | 1.91B | 20.78B | 26.38B | 18.68B | 7.29B | 5.98B |
| Dividends paid | -2.67B | -3.34B | -2.33B | -1.80B | -5.38B | -10.91B | -8.58B | -4.79B |
| Stock buybacks / issuance | 0 | -442.00M | -1.06B | -321.00M | -3.32B | -5.59B | -6.01B | -5.92B |
| Ending cash balance | 7.56B | 5.18B | 6.76B | 13.99B | 15.58B | 8.07B | 5.90B | 5.04B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 9.04B | 2.48B | 6.35B | 2.11B | 5.21B | 9.47B |
| Depreciation & amortization | 2.31B | 3.43B | 3.37B | 3.37B | 2.53B | 2.72B |
| Free cash flow | 6.01B | -924.00M | 2.93B | -2.04B | 2.10B | 6.60B |
| Dividends paid | -1.91B | -1.02B | -938.00M | -918.00M | -920.00M | -971.00M |
| Stock buybacks / issuance | -549.00M | -265.00M | -4.71B | -389.00M | -271.00M | -83.00M |
| Ending cash balance | 7.37B | 9.44B | 8.11B | 5.04B | 5.92B | 8.06B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 18.19 | 4.38 | -14.69 | 23.50 | 61.82 | 23.20 | 19.39 | 12.19 |
| ROA %i | 6.74 | 1.60 | -4.59 | 6.36 | 18.84 | 7.88 | 6.41 | 3.84 |
| ROIC %i | 11.43 | 3.29 | -6.94 | 12.33 | 35.43 | 13.24 | 10.77 | 6.78 |
| 5-year avg ROE %i | 3.68 | 3.14 | 2.48 | 8.73 | 18.64 | 19.64 | 22.64 | 28.02 |
| EBIT margin %i | 24.76 | 16.35 | -7.17 | 36.46 | 53.38 | 36.51 | 31.26 | 24.49 |
| FCF / sales %i | 10.60 | 5.63 | 4.17 | 23.41 | 17.80 | 13.22 | 7.74 | 5.65 |
| Current ratioi | 1.57 | 1.27 | 1.62 | 1.60 | 1.78 | 1.71 | 1.48 | 1.27 |
| Quick ratioi | 1.39 | 1.07 | 1.30 | 1.31 | 1.41 | 1.54 | 1.13 | 1.11 |
| Debt / assetsi | 22.87 | 24.22 | 30.54 | 24.63 | 20.36 | 22.14 | 22.95 | 23.70 |
| LT debt / equityi | 54.14 | 60.64 | 95.47 | 76.53 | 49.18 | 50.57 | 51.07 | 64.28 |
| Interest coveragei | 33.65 | 10.36 | -3.35 | 42.07 | 85.61 | 34.76 | 30.32 | 31.15 |
| Revenue CAGR (3Y) %i | 10.70 | 11.25 | -9.13 | 4.15 | 33.30 | 32.67 | 4.92 | -10.78 |
| Net income CAGR (3Y) %i | -- | -- | -- | 4.36 | 149.85 | -- | 0.94 | -44.02 |
| FCF CAGR (3Y) %i | -- | -- | -22.14 | 35.63 | 95.23 | 113.86 | -29.47 | -39.04 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 18.28 | 19.20 | 13.49 | 12.19 | 12.35 | 21.32 |
| ROA %i | 6.37 | 6.01 | 4.23 | 3.84 | 3.96 | 6.47 |
| ROIC %i | 10.72 | 10.30 | 7.58 | 6.78 | 7.18 | 11.97 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 30.76 | 29.15 | 26.55 | 24.49 | 25.78 | 30.12 |
| FCF / sales %i | 6.83 | 7.05 | 6.57 | 5.65 | 1.98 | 8.43 |
| Current ratioi | 1.54 | 1.47 | 1.48 | 1.27 | 1.24 | 1.18 |
| Quick ratioi | 1.22 | 1.06 | 1.05 | 1.11 | 1.03 | 1.05 |
| Debt / assetsi | 21.59 | 24.69 | 22.79 | 23.70 | 22.57 | 23.01 |
| LT debt / equityi | 49.62 | 58.45 | 61.86 | 64.28 | 57.23 | 56.30 |
| Interest coveragei | 34.00 | 33.66 | 30.96 | 31.15 | 28.59 | 33.43 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Marketing, Midstream & Processing (MMP) is the largest reported line at 95.80% of revenue, across 7 reported segments.
- The next-largest line, Exploration & Production (E&P) Norway, is a distant second at 37.54% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Marketing, Midstream & Processing (MMP)95.80%
Exploration & Production (E&P) Norway37.54%
Exploration & Production (E&P) International5.73%
Exploration & Production (E&P) USA4.97%
Power2.96%
Other0.17%
Quote time 2026-10-08 07:00:07 · For reference only, not investment advice and not tailored to your situation.